A novel candidate region for ALS on chromosome 14q11.2

Sequence variations with biologic effect in ALS have been identified in the gene for vascular endothelial growth factor (VEGF). The gene for a related protein, angiogenin, lies on chromosome 14q11.2. Analysis of the angiogenin (ANG) gene in the authors’ population has demonstrated a significant allelic association with the rs11701 single nucleotide polymorphism (SNP) and identified a novel mutation in two individuals with sporadic ALS that potentially inhibits angiogenin function. These observations propose a candidate region for ALS on chromosome 14q11.2 and suggest that other genes with similar function to VEGF may be important in the pathogenesis of ALS.

[1]  R. Gay,et al.  Angiogenic and angiostatic factors in the molecular control of angiogenesis. , 2003, The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology.

[2]  P. Shaw,et al.  Screening of AP endonuclease as a candidate gene for amyotrophic lateral sclerosis (ALS) , 2000, Neuroreport.

[3]  C. Hayward,et al.  Molecular genetic analysis of the APEX nuclease gene in amyotrophic lateral sclerosis , 1999, Neurology.

[4]  O. Hardiman,et al.  Incidence and prevalence of ALS in Ireland, 1995–1997 , 1999, Neurology.

[5]  S. Leeder,et al.  A population based study , 1993, The Medical journal of Australia.

[6]  T. Hallahan,et al.  Dual site model for the organogenic activity of angiogenin. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[7]  E. Fox,et al.  Role of lysines in human angiogenin: chemical modification and site-directed mutagenesis. , 1989, Biochemistry.

[8]  J. L. Swain,et al.  Tissue distribution and developmental expression of the messenger RNA encoding angiogenin. , 1987, Science.

[9]  J F Riordan,et al.  Amino acid sequence of human tumor derived angiogenin. , 1985, Biochemistry.

[10]  P. Carmeliet,et al.  VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death , 2003, Nature Genetics.

[11]  Till Acker,et al.  Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration , 2001, Nature Genetics.